System and method for improved detection and assessment of changes in lung-tissue structure

• US 20070197903A1
• Filed: 03/09/2005
• Published: 08/23/2007
• Est. Priority Date: 03/10/2004
• Status: Abandoned Application

• Current Assignee: University of Virginia Patent Foundation (University of Virginia)
• Original Assignee: University of Virginia Patent Foundation (University of Virginia)
• Inventors: Mugler, John, Brookeman, James, Altes, Talissa, Mata, Jaime
• Application Number:
  US10/592,186
• Publication Number:
  US 20070197903A1
• Time in Patent Office: Days
• US Class Current: 600/420
• CPC Class Codes: A61B 5/055 involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
• CPC Class Codes: A61B 5/085 Measuring impedance of respiratory organs or lung elasticity
• CPC Class Codes: A61B 5/726 using Wavelet transforms

Abstract

A method and system is described for measuring the apparent diffusion coefficient of Xe129 in the lung as a means to detect and assess changes in lung-tissue structure such as those that occur in certain pulmonary diseases. The main steps of this process include: polarizing the Xe129 gas; introducing said gas into the lung; acquiring sets of Xe 129 M R signals with various diffusion sensitizations; calculating Xe 129 ADC values; and evaluating said ADC values by comparison of the values in a region of interest to those in different regions of the lung or to normative values.

Claims

1. A method for detecting or assessing changes in lung-tissue in a lung, said method comprising:

generating hyperpolarized Xe129 gas;

introducing said gas into the lung after the lung is positioned within an appropriate radio-frequency coil that is within a magnetic resonance imaging (MRI) apparatus;

acquiring at least two magnetic resonance signals from Xe129 nuclei within the lung wherein said signals are “

diffusion sensitized”

such that the value of a property of said signals varies between the signals and reflects, among other possible effects, the degree to which diffusion has affected said signals;

calculating apparent diffusion coefficient values from said diffusion-sensitized magnetic resonance signals; and

evaluating apparent diffusion coefficient values.

2. The method of claim 1, wherein said generating said gas is by optical pumping and spin exchange.

3. The method of claim 1, wherein in addition to said hyperpolarized Xe129 at least one other gas is introduced into said lung.

4. The method of claim 3, wherein said at least one other gas have the purpose of modifying the apparent diffusion coefficient of said hyperpolarized Xe129.

5. The method of claim 1, wherein said gas'"'"'s volume and nuclear polarization are chosen based on at least one of the volume of the lung, and the desired spatial resolution, desired temporal resolution and desired signal-to-noise ratio of magnetic resonance signals to be generated.

6. The method of claim 1, wherein said introducing of said gas into the lung is by inhalation from a plastic bag, inhalation from a computer controlled gas mixing system, introduction by depressing a gas-filled syringe, or introduction by using a computer-controlled or manually-controlled ventilation device.

7. The method of claim 1, wherein said acquiring of said diffusion-sensitized magnetic resonance signals occurs during inhalation, during exhalation, during breath-holding, or some combination thereof.

8. The method of claim 1, wherein said calculating of said apparent diffusion coefficient values from said diffusion-sensitized magnetic resonance signals from Xe129 nuclei includes correcting said signals for the extraneous effect(s) of at least one of T1 decay, T2 decay, T2* decay and RF pulses.

9. The method of claim 1, wherein at least two values of diffusion sensitization are used.

10. The method of claim 1, wherein the method of diffusion sensitization involves modulating the phase of the transverse magnetization along at least one spatial direction by using at least one magnetic field gradient pulse.

11. The method of claim 10, wherein a bipolar magnetic field gradient pulse is used to modulate the phase of the transverse magnetization.

12. The method of claim 11, wherein a time delay is inserted between the positive and negative portions of the bipolar magnetic field gradient pulse.

13. The method of claim 11, wherein, to achieve a higher degree of diffusion sensitization while maintaining a chosen fundamental time period of diffusion sensitization, the bipolar magnetic field gradient pulse is applied at least twice prior to acquiring a given diffusion-sensitized magnetic resonance signal.

14. The method of claim 11, wherein bipolar gradients of opposite senses are applied back-to-back to achieve compensation for bulk motion.

15. The method of claim 1, wherein the method of diffusion sensitization involves modulating the amplitude of the longitudinal magnetization along at least one spatial direction by using at least two radio-frequency pulses interspersed with at least one magnetic field gradient pulse.

16. The method of claim 15, wherein the effect of diffusion on the modulated longitudinal magnetization is monitored by acquiring at least two magnetic resonance images that are separated by appropriately chosen time delays.

17. The method of claim 1, wherein said diffusion-sensitized magnetic resonance signals reflect the signal from all Xe129 nuclei within the lung.

18. The method of claim 1, wherein said diffusion-sensitized magnetic resonance signals reflect the signal from Xe129 nuclei within one or more selected sub-volumes within the whole of the lung, wherein each said sub-volume may correspond to a planar slice of lung tissue, a column of lung tissue, or some arbitrarily-shaped volume of lung tissue.

19. The method of claim 1, wherein said property of said diffusion-sensitized magnetic resonance signals that reflects the effect of diffusion is the amplitude of the signals.

20. The method of claim 1, wherein at least one magnetic field gradient pulse is applied for at least one of before and during the acquiring of said diffusion-sensitized magnetic resonance signals in any manner consistent with imaging pulse sequences known in the art to permit a diffusion-sensitized magnetic resonance image, resolved in one, two or three spatial dimensions, to be calculated.

21. The method of claim 20, wherein diffusion-sensitized magnetic resonance images are acquired corresponding to one or more spatial locations.

22. The method of claim 20, wherein said calculating of said apparent diffusion coefficient values yields spatially resolved maps of said values.

23. The method of claim 22, wherein said acquiring of said diffusion-sensitized magnetic resonance images is performed by using a gradient-echo pulse sequence.

24. The method of claim 23, wherein said gradient-echo pulse sequence incorporates a bipolar gradient waveform just after the excitation radio-frequency pulse for diffusion sensitization.

25. The method of claim 1, wherein said calculating of said apparent diffusion coefficient values is performed from the signals corresponding to the different diffusion sensitizations by using linear least squares fitting of the natural logarithm of the signal intensities versus the degree of diffusion sensitization.

26. The method of claim 1, wherein the lung is the lung of an animal or of a human.

27. The method of claim 26, wherein the lung may be in vivo or excised.

28. An MRI apparatus for detecting or assessing changes in lung-tissue structure of a lung using hyperpolarized Xe129 gas, said apparatus comprising:

a radio frequency coil, wherein the gas is introduced into the lung and the lung is positioned within said radio-frequency coil;

an MR images acquisition means, said MR images acquisition means acquiring at least two magnetic resonance signals from Xe129 nuclei within the lung wherein said signals are “

diffusion sensitized”

such that the value of a property of said signals varies between the signals and reflects, among other possible effects, the degree to which diffusion has affected said signals;

calculating means, said calculating means for calculating apparent diffusion coefficient values from said diffusion-sensitized resonance signals; and

an evaluating means, said evaluating means for evaluating coefficient values.

29. The apparatus of claim 28, further comprising a gas generating means for providing the hyperpolarized Xe129 gas.

30. The apparatus of claim 29, wherein said generating means hyperpolarizes said gas by optical pumping and spin exchange.

31. The apparatus of claim 28, wherein in addition to said hyperpolarized Xe129 at least one other gas is introduced into said lung.

32. The apparatus of claim 31, wherein said at least one other gas have the purpose of modifying the apparent diffusion coefficient of said hyperpolarized Xe129.

33. The apparatus of claim 28, wherein said gas'"'"'s volume and nuclear polarization are chosen based on at least one of the volume of the lung, and the desired spatial resolution, desired temporal resolution and desired signal-to-noise ratio of magnetic resonance signals to be generated.

34. The apparatus of claim 28, wherein said gas introduced into the lung is by inhalation from a plastic bag, inhalation from a computer controlled gas mixing system, introduction by depressing a gas-filled syringe, or introduction by using a computer-controlled or manually-controlled ventilation device.

35. The apparatus of claim 28, wherein said acquisition of said diffusion-sensitized magnetic resonance signals occurs during inhalation, during exhalation, during breath-holding, or some combination thereof.

36. The apparatus of claim 28, wherein said calculation of said apparent diffusion coefficient values from said diffusion-sensitized magnetic resonance signals from Xe129 nuclei includes correcting said signals for the extraneous effect(s) of at least one of T1 decay, T2 decay, T2* decay arid RF pulses.

37. The apparatus of claim 28, wherein at least two values of diffusion sensitization are used.

38. The apparatus of claim 28, wherein said diffusion-sensitized signals involves modulating the phase of the transverse magnetization along at least one spatial direction by using at least one magnetic field gradient pulse.

39. The apparatus of claim 38, wherein a bipolar magnetic field gradient pulse is used to modulate the phase of the transverse magnetization.

40. The apparatus of claim 39, wherein a time delay is inserted between the positive and negative portions of the bipolar magnetic field gradient pulse.

41. The apparatus of claim 39, wherein, to achieve a higher degree of diffusion sensitization while maintaining a chosen fundamental time period of diffusion sensitization, the bipolar magnetic field gradient pulse is applied at least twice prior to acquiring a given diffusion-sensitized magnetic resonance signal.

42. The apparatus of claim 39, wherein bipolar gradients of opposite senses are applied back-to-back to achieve compensation for bulk motion.

43. The apparatus of claim 28, wherein the diffusion-sensitized signals involves modulating the amplitude of the longitudinal magnetization along at least one spatial direction by using at least two radio-frequency pulses interspersed with at least one magnetic field gradient pulse.

44. The apparatus of claim 43, wherein the effect of diffusion on the modulated longitudinal magnetization is monitored by acquiring at least two magnetic resonance images that are separated by appropriately chosen time delays.

45. The apparatus of claim 28, wherein said diffusion-sensitized magnetic resonance signals reflect the signal from all Xe129 nuclei within the lung.

46. The apparatus of claim 28, wherein said diffusion-sensitized magnetic resonance signals reflect the signal from Xe129 nuclei within one or more selected sub-volumes within the whole of the lung, wherein each said sub-volume may correspond to a planar slice of lung tissue, a column of lung tissue, or some arbitrarily-shaped volume of lung tissue.

47. The apparatus of claim 28, wherein said property of said diffusion-sensitized magnetic resonance signals that reflects the effect of diffusion is the amplitude of the signals.

48. The apparatus of claim 28, wherein at least one magnetic field gradient pulse is applied for at least one of before and during the acquiring of said diffusion-sensitized magnetic resonance signals in any manner consistent with imaging pulse sequences known in the art to permit a diffusion-sensitized magnetic resonance image, resolved in one, two or three spatial dimensions, to be calculated.

49. The apparatus of claim 48, wherein diffusion-sensitized magnetic resonance images are acquired corresponding to one or more spatial locations.

50. The apparatus of claim 48, wherein said calculating of said apparent diffusion coefficient values yields spatially resolved maps of said values.

51. The apparatus of claim 50, wherein said acquiring of said diffusion-sensitized magnetic resonance images is performed by using a gradient-echo pulse sequence.

52. The apparatus of claim 51, wherein said gradient-echo pulse sequence incorporates a bipolar gradient waveform just after the excitation radio-frequency pulse for diffusion sensitization.

53. The apparatus of claim 28, wherein said calculation of said apparent diffusion coefficient values is performed from the signals corresponding to the different diffusion sensitizations by using linear least squares fitting of the natural logarithm of the signal intensities versus the degree of diffusion sensitization.

54. The apparatus of claim 28, wherein the lung is the lung of an animal or of a human.

55. The method of claim 54, wherein the lung may be in vivo or excised.